Insider Transactions Reported by 25 Insiders of Health Catalyst, Inc.

Symbol
HCAT on Nasdaq
Location
South Jordan, UT

Insiders trading volume in the past year

Health Catalyst, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Mathew Paul Arens Director, 10%+ Owner $32,429,283 01 Dec 2025
Daniel D. Burton Chief Executive Officer, Director $4,040,265 01 Dec 2025
Benjamin Albert CEO, Director $3,041,581 02 Mar 2026
James Patrick Nelli Jr. President $2,869,452 01 Sep 2022
Paul Horstmeier Chief Operating Officer $2,218,256 22 Mar 2023
Bryan Truman Hunt Chief Financial Officer $1,770,048 01 Mar 2024
Jason Alger Chief Financial Officer $1,475,871 02 Mar 2026
Daniel Orenstein General Counsel $1,441,055 01 Mar 2023
Kevin Lee Freeman Chief Commercial Officer $1,040,261 01 Dec 2025
Benjamin Landry General Counsel $752,852 -$116,923 -13% 02 Mar 2026
Anne Marie Bickmore COO and Chief Product Officer $689,903 01 Dec 2023
David Coy Ross Chief Tech & Product Officer $686,727 02 Sep 2025
Daniel LeSueur Chief Operating Officer $667,048 -$42,936 -6% 02 Sep 2025
Linda Llewelyn Chief People Officer $656,005 02 Mar 2026
KANE JOHN A Director $643,610 09 Jul 2025
Anita Pramoda Director $494,318 01 Dec 2024
D. Fraser Bullock Director $487,209 10 Jun 2021
MARK B. TEMPLETON Director $426,155 14 Jun 2023
S. Dawn Smith Director $383,378 09 Jul 2025
Bryan Richard Hinton Chief Technology Officer $285,868 01 Sep 2022
Duncan Gallagher Director $285,169 17 Feb 2026
Green Jill Hoggard Director $241,042 09 Jul 2025
Justin Spencer Director $194,058 01 Sep 2025
Julie Larson-Green Director $163,048 -$128,349 -44% 01 Mar 2026
Matthew Kolb Director 01 Jul 2023

Recent Insider Transactions by Companies or Individuals for Health Catalyst, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.